TNFRSF11B and metabolic dysfunction-associated steatotic liver disease: A2M (Fig. 5C) and TNFRSF11B (Fig. 5E) in the liver from the donor (left panels) and NAFLD patients (right panels) were also detected immunohistochemically, with increased staining in NAFLD patients mainly located in the cytoplasm.